3-hydroxybutyric acid has been researched along with Diabetic Neuropathies in 4 studies
3-Hydroxybutyric Acid: BUTYRIC ACID substituted in the beta or 3 position. It is one of the ketone bodies produced in the liver.
3-hydroxybutyric acid : A straight-chain 3-hydroxy monocarboxylic acid comprising a butyric acid core with a single hydroxy substituent in the 3- position; a ketone body whose levels are raised during ketosis, used as an energy source by the brain during fasting in humans. Also used to synthesise biodegradable plastics.
Diabetic Neuropathies: Peripheral, autonomic, and cranial nerve disorders that are associated with DIABETES MELLITUS. These conditions usually result from diabetic microvascular injury involving small blood vessels that supply nerves (VASA NERVORUM). Relatively common conditions which may be associated with diabetic neuropathy include third nerve palsy (see OCULOMOTOR NERVE DISEASES); MONONEUROPATHY; mononeuropathy multiplex; diabetic amyotrophy; a painful POLYNEUROPATHY; autonomic neuropathy; and thoracoabdominal neuropathy. (From Adams et al., Principles of Neurology, 6th ed, p1325)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dejgaard, A | 1 |
| Andersen, P | 1 |
| Hvidberg, A | 1 |
| Hilsted, J | 1 |
| Bottini, P | 1 |
| Boschetti, E | 1 |
| Pampanelli, S | 1 |
| Ciofetta, M | 1 |
| Del Sindaco, P | 1 |
| Scionti, L | 1 |
| Brunetti, P | 1 |
| Bolli, GB | 1 |
| Wahrenberg, H | 1 |
| Arner, P | 1 |
| Adamsson, U | 1 |
| Lins, PE | 1 |
| Juhlin-Dannfelt, A | 1 |
| Ostman, J | 1 |
| Scheen, AJ | 1 |
| Gillet, J | 1 |
| Rosenthaler, J | 1 |
| Guiot, J | 1 |
| Henrivaux, P | 1 |
| Jandrain, B | 1 |
| Lefèbvre, PJ | 1 |
4 other studies available for 3-hydroxybutyric acid and Diabetic Neuropathies
| Article | Year |
|---|---|
Cardiovascular, metabolic, and hormonal responses to noradrenaline in diabetic patients with autonomic neuropathy.
Topics: 3-Hydroxybutyric Acid; Adrenergic alpha-Agonists; Adult; Blood Glucose; Blood Pressure; Cardiac Outp | 1996 |
Contribution of autonomic neuropathy to reduced plasma adrenaline responses to hypoglycemia in IDDM: evidence for a nonselective defect.
Topics: 3-Hydroxybutyric Acid; Autonomic Nervous System Diseases; Blood Glucose; Carbon Dioxide; Diabetes Me | 1997 |
Increased lipolytic sensitivity to catecholamines in diabetic patients with severe autonomic neuropathy.
Topics: 3-Hydroxybutyric Acid; Adipose Tissue; Adult; Autonomic Nervous System Diseases; Blood Glucose; Cate | 1990 |
Sandostatin, a new analogue of somatostatin, reduces the metabolic changes induced by the nocturnal interruption of continuous subcutaneous insulin infusion in type 1 (insulin-dependent) diabetic patients.
Topics: 3-Hydroxybutyric Acid; Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Diabetic Neuropat | 1989 |